You have completed this training and quiz.
Your score is: 13
Score
13/13
Pass
13/13
Fail
12/13
Growth hormone (GH) is secreted by the _________________________.
anterior lobe of the pituitary gland
posterior lobe of the pituitary gland
hypothalamus
thyroid gland
When do the highest peaks in growth hormone (GH) typically occur?
Within 30 minutes of falling asleep
During the first 2 hours of deep sleep
3 hours after falling asleep
After 4 hours of deep sleep
What hormones stimulate the secretion of growth hormone (GH)?
Growth hormone-releasing hormone (GHRH) and ghrelin
Somatostatin and growth hormone-releasing hormone (GHRH)
Somatomedins (insulin-like growth factors [IGFs]) and ghrelin
Somatostatin and somatomedins (insulin-like growth factors [IGFs])
Congenital growth hormone (GH) deficiency differs from acquired GH deficiency in that it __________________________________.
is a complication of central nervous system (CNS) infection
can be caused by trauma or autoimmune diseases
results due to structural malformations of the brain
develops after birth
Which of the following growth disorders is characterized by hypotonia and failure to thrive in the postnatal period, as well as short stature, cognitive disabilities, hyperphagia, and obesity following the postnatal period?
Turner syndrome (TS)
Prader-Willi syndrome (PWS)
Idiopathic short stature (ISS)
Small for gestational age (SGA)
All of the following are part of the diagnosis of growth hormone deficiency (GHD) and growth hormone disorders except for what?
Physical examination
Growth hormone (GH) stimulation tests
Laboratory studies
Ultrasound/sonography
What is the recommended dosage of OMNITROPE® for the treatment of pediatric growth hormone deficiency (GHD)?
0.16 to 0.24 mg/kg body weight per week divided over 6 or 7 days of subcutaneous injections
0.24 mg/kg/day
0.33 mg/kg/week in divided doses given on 3 alternate days, 6 times per week, or daily
0.5 mg/kg/day
The use of OMNITROPE® is contraindicated in patients with ______________.
pancreatitis
fluid retention
active malignancy
lipoatrophy
The following topic is listed as a warning/precaution in the OMNITROPE® label because it has been associated with serious adverse events and death, particularly in pediatric patients (ie, “gasping syndrome”).
Prader-Willi syndrome (PWS) in children
Neoplasms
Hypersensitivity
Benzyl alcohol
Which of the following is NOT a responsibility of the registered nurse (RN)?
Confirm that the pen/vial education checklist is correct and complete post-visit
Administer the medication to show the proper dose and technique
Provide side-by-side instruction to the patient/caregiver on injection administration
Complete the pre-scheduling checklist prior to contacting patients
Copy and paste this link and scroll down to watch the pen device video.
Once you have viewed the entire video, please answer the question below.
Have you watched the entire video?
Yes
No
Copy and paste the below link. Once you get to the website scroll down and watch the vial video.
https://www.omnitrope.com/your-omnisource/injection-training#
Once you have viewed the entire video, please answer the question below.
Have you watched the entire video?
Yes
No
Can you give the patient an injection during your visit?
Yes
No
Please enter your first and last name.
Please enter the name of the home health organization/company you work for and the location.
Email: please enter your email for test results
What is your zip code?
Make a Quiz
It's free to start.
It's free to start.